(Q48681270)

14 February 2018

title

Anti-galectin-1 autoantibodies in serum of patients with neurological diseases. (English)

1 reference

14 February 2018

1 reference

D Lutomski

1

1 reference

14 February 2018

R Joubert-Caron

2

1 reference

14 February 2018

C Lefebure

3

1 reference

14 February 2018

J Salama

4

1 reference

14 February 2018

C Belin

5

1 reference

14 February 2018

D Bladier

6

1 reference

14 February 2018

M Caron

7

1 reference

14 February 2018

publication date

1 June 1997

1 reference

14 February 2018

published in

Clinica Chimica Acta

1 reference

14 February 2018

volume

262

1 reference

14 February 2018

issue

1-2

1 reference

14 February 2018

page(s)

131-138

1 reference

14 February 2018

Oligoclonal beta-galactoside-binding immunoglobulins antigenically related to 14 kDa lectin in human serum and cerebrospinal fluid: purification and characterization.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Soluble galactoside-binding vertebrate lectins: a protein family with common properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Biotinylated derivative of a human brain lectin: synthesis and use in affinoblotting for endogenous ligand studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Purification and characterization of a galactoside-binding lectin from human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Human brain lectin immunoreactive material in cerebrospinal fluids determined by enzyme immunoassay (EIA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

?-Galactoside soluble lectin from human brain: complete amino acid sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Identification of an autocrine negative growth factor: mouse beta-galactoside-binding protein is a cytostatic factor and cell growth regulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Identification of different galectins by immunoblotting after two-dimensional polyacrylamide get electrophoresis with immobilized pH gradients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Changes in S-type lectin localization in neuroblastoma cells (N1E115) upon differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Purification and characterization of natural antibodies that recognize a human brain lectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Autoantiidiotypic antibodies in myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

Evidence for IgG autoantibodies to galectin-3, a beta-galactoside-binding lectin (Mac-2, epsilon binding protein, or carbohydrate binding protein 35) in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2906544-3

10.1016/S0009-8981(97)06544-3

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

9204215

1 reference

14 February 2018